HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
PFE
Pfizer Inc
Healthcare Drug Manufacturers - General · New York, USA · Reports in usd
Market Cap: $150.86B
Market Cap
$150.86B
Enterprise Val
$202.24B
P/E Ratio
20.14
P/B Ratio
1.67
Trailing PEG (1Y)
-2.09
As Of
May 5, 2026

Overview & Key Metrics

Reporting period: Mar 29, 2026 · Q1 2026
Book Value$90.40B
Gross Margin75.45%
Profit Margin75.45%
Return on Equity8.37%
Return on Assets3.61%
Current Ratio1.25
Debt/Equity0.72
LT Debt/Equity0.67
Revenue Per Share2.54

Income Statement

Mar 29, 2026
Revenue$14.45B
Cost of Revenue$3.55B
Gross Profit$10.90B
R&D$2.49B
SG&A$2.96B
Operating Expenses$7.73B
Operating Income$3.17B
Interest Expense$0.00
Tax Expense$461.0M
Net Income$2.69B
EPS (Basic)$0.47
EPS (Diluted)$0.47
EBIT$3.15B
EBITDA$4.76B
Consolidated Income$2.70B
Non-Controlling Interests$8.0M

Balance Sheet

Mar 29, 2026
Cash & Equivalents$1.70B
Accounts Receivable$12.59B
Inventory$10.67B
Current Assets$42.82B
LT Investments$1.63B
Property, Plant & Equipment$19.40B
Intangibles$123.97B
Non-Current Assets$164.80B
Total Assets$207.62B
Accounts Payable$4.51B
Current Debt$3.89B
Current Liabilities$34.35B
LT Debt$60.57B
Non-Current Liabilities$82.87B
Total Liabilities$117.21B
Total Debt$64.46B
Retained Earnings$117.24B
Shareholder Equity$90.10B
Shares Outstanding5,686,267,431

Cash Flow Statement

Mar 29, 2026
Operating Cash Flow$2.62B
Investing Cash Flow$785.0M
Financing Cash Flow-$2.86B
CapEx-$436.0M
Free Cash Flow$2.18B
Depreciation & Amort.$1.61B
Stock-Based Comp$272.0M
Acquisitions / Disposals$0.00
Investment Activity$1.20B
Debt Issued/Repaid-$127.0M
Equity Issued/Repaid$0.00
Dividends Paid-$2.45B
Net Change in Cash$563.0M
Data cached · Meta live · Daily live · Statements live · TTL 24h